Many studies have shown that in type 2 diabetes, FOXO1 is involved in glucose and lipid metabolism, insulin resistance, and β-cell proliferation, differentiation, and apoptosis, making it an important target for potential therapeutic intervention (38). This evidence concerns the gene FOXO1 and type 2 diabetes mellitus.